Megavitamin therapy

From Wikipedia, the free encyclopedia
  (Redirected from Megadosing)
Jump to: navigation, search
Megavitamin therapy
Claims Health effects from very high doses of vitamins.
Related scientific disciplines vitamins, dietary supplements
Year proposed 1930s
Notable proponents Fred R. Klenner, Linus Pauling
Pseudoscientific concepts

Megavitamin therapy is the use of large doses of vitamins, often many times greater than the recommended dietary allowance (RDA) in the attempt to prevent or treat diseases. Megavitamin therapy is typically used in alternative medicine by practitioners who call their approach "orthomolecular medicine", but also used in mainstream medicine for "exceedingly rare" genetic conditions that respond to megadoses of vitamins.[1]

In 2002, a review of these conditions identified about 50 that respond to "high-dose vitamin therapy".[2] Further understanding of these conditions is expected to play a part in the emerging field of nutrigenomics.[3]

Nutrients may be useful in preventing and treating some illnesses,[4] but the conclusions of medical research are that the broad claims of disease treatment by advocates of megavitamin therapy are unsubstantiated by the available evidence.[4][5][6] It is generally accepted that doses of any vitamin greatly in excess of nutritional requirements, will result either in toxicity or in the excess simply being metabolised - evidence in favour of vitamin supplementation supports only doses in the normal range.[7][8][9] Critics have described some aspects of orthomolecular medicine as food faddism or even quackery.[10][11][12] Research on nutrient supplementation in general suggests that some nutritional supplements might be beneficial, and that others might be harmful;[13][14][15] several specific nutritional therapies are associated with an increased likelihood of the condition they are meant to prevent.[16]

Multivitamin vs megavitamin[edit]

Megavitamin therapy must be distinguished from the usual 'vitamin supplementation' approach of traditional multivitamin pills. Megavitamin doses are far higher than the levels of vitamins ordinarily available through western diets. Multivitamin supplementation has been demonstrated to have negligible effect in treating cancer.

A study of 161,000 individuals (post-menopausal women) provided, in the words of the authors, "convincing evidence that multivitamin use has little or no influence on the risk of common cancers, cardiovascular disease, or total mortality in postmenopausal women".[17]


In the 1930s and 1940s, some scientific and clinical evidence suggested that there might be beneficial uses of vitamins C, E, and B3 in large doses. Beginning in the 1930s, the Shutes in Canada developed a megadose vitamin E therapy for cardiovascular and circulatory complaints, naming it the "Shute protocol".[18]

Tentative experiments in the 1930s[19] with larger doses of vitamin C were superseded by Fred R. Klenner's development of megadose intravenous vitamin C treatments for polio and other viruses in the 1940s.[20] William Kaufman published articles in the 1940s that detailed his treatment of arthritis with frequent, high doses of niacinamide.[21]

In 1954, Rudolf Altschul and Abram Hoffer applied large doses of the immediate release form of niacin (Vitamin B3) to treat hypercholesterolemia.[22] In a 1956 publication entitled Biochemical Individuality, Roger J. Williams introduced concepts for individualized megavitamins and nutrients.[23] Megavitamin therapies were also publicly advocated by Linus Pauling in the late 1960s.[24] In 1956, experimental results suggested niacin could be useful in the treatment of high cholesterol, results that were confirmed in 1986.[25]

Usage of therapy[edit]

An American cottage industry in the late 20th century, evolving megavitamin therapies are integrated with orthomolecular and naturopathic medicine.

Although megavitamin therapies still largely remain outside of the structure of evidence-based medicine, they are increasingly used by patients, with or without the approval of their treating physicians.[26]

In 2008, researchers established that higher vitamin C intake reduces serum uric acid levels and may be useful in the prevention of gout.[27]

The proposed efficacy of various megavitamin therapies to reduce cancer risk has been contradicted by results of one clinical trial.[28] A review of clinical trials in the treatment of colds with small and large doses of Vitamin C has established that there is no evidence for its efficacy.[29][needs update] After 33 years of research, it is still not established whether vitamin C can be used as a treatment for cancer.[30]

While some vitamins have no known tolerable upper intake level, others, including vitamins A[31] and D,[31] are known to be toxic at high doses. All vitamins known to be toxic in high doses are fat-soluble, not water-soluble, as water-soluble vitamins can be voided via urine within a reasonable timeframe.

Because vitamin intake can alter metabolism as much as medications, short term vacations from any single or multivitamin intake are generally recommended (by the medical and homeopathic communities) so as to allow the body to use up excess vitamin reserves and stabilize its internal chemistry.

See also[edit]

Related topics

Vitamin topics


  1. ^ Menolascino FJ, Donaldson JY, Gallagher TF, Golden CJ, Wilson JE (1988). "Orthomolecular therapy: its history and applicability to psychiatric disorders". Child Psychiatry Hum Dev. 18 (3): 133–50. doi:10.1007/BF00709727. PMID 2898324. 
  2. ^ Ames BN, Elson-Schwab I, Silver EA (April 2002). "High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms". Am. J. Clin. Nutr. 75 (4): 616–58. PMID 11916749. 
  3. ^ Kaput J, Rodriguez RL (January 2004). "Nutritional genomics: the next frontier in the postgenomic era". Physiol. Genomics. 16 (2): 166–77. doi:10.1152/physiolgenomics.00107.2003. PMID 14726599. 
  4. ^ a b "ACS : Orthomolecular Medicine". American Cancer Society. 2007-06-19. Retrieved 2008-04-04. 
  5. ^ Aaronson S, et al. (2003). "Cancer medicine". Cancer medicine 6 (Frei, Emil; Kufe, Donald W.; Holland, James F., eds). Hamilton, Ont: BC Decker. p. 76. ISBN 1-55009-213-8. 
  6. ^ Nutrition Committee; Canadian Paediatric Society (1 January 1990). "Megavitamin and megamineral therapy in childhood. Nutrition Committee, Canadian Paediatric Society". CMAJ. 143 (10): 1009–1013. PMC 1452516Freely accessible. PMID 1699646. 
  7. ^
  8. ^
  9. ^ Novella, S: Medical Myths, Lies, and Half-Truths: What We Think We Know May Be Hurting Us, The Great Courses
  10. ^ Jarvis WT (1983). "Food faddism, cultism, and quackery". Annu. Rev. Nutr. 3: 35–52. doi:10.1146/ PMID 6315036. 
  11. ^ Jukes, T.H. (1990). "Nutrition Science from Vitamins to Molecular Biology". Annual Review of Nutrition. 10 (1): 1–20. doi:10.1146/ PMID 2200458.  A short summary is in the journal's preface.
  12. ^ Braganza, S.F.; Ozuah, P.O. (2005). "Fad Therapies". Pediatrics in Review. 26 (10): 371–376. doi:10.1542/pir.26-10-371. PMID 16199591. 
  13. ^ "NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention". NIH Consens State Sci Statements. 23 (2): 1–30. 2006. PMID 17332802. 
  14. ^ Huang HY, Caballero B, Chang S, et al. (September 2006). "The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference". Ann. Intern. Med. 145 (5): 372–85. doi:10.1001/archinte.145.2.372. PMID 16880453. 
  15. ^ Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2012). "Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases". Cochrane Database Syst Rev. 3: CD007176. doi:10.1002/14651858.CD007176.pub2. PMID 22419320. 
  16. ^ Satia JA, Littman A, Slatore CG, Galanko JA, White E (2009). "Long-term Use of {beta}-Carotene, Retinol, Lycopene, and Lutein Supplements and Lung Cancer Risk: Results From the VITamins And Lifestyle (VITAL) Study". American Journal of Epidemiology. 169 (7): 815–28. doi:10.1093/aje/kwn409. PMC 2842198Freely accessible. PMID 19208726. 
  17. ^ Neuhouser ML, Wassertheil-Smoller S, Thomson C, et al. (February 2009). "Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts". Arch. Intern. Med. 169 (3): 294–304. doi:10.1001/archinternmed.2008.540. PMID 19204221. 
  18. ^ Vogelsang A, Shute E, Shute W (February 1948). "Some medical uses of vitamin E". Med World (New York). 161 (2): 83–9. PMID 18911314. 
  19. ^ Jungeblut, CW (1937). "Vitamin C Therapy and Prophylaxis in Experimental Poliomyelitis". The Journal of Experimental Medicine. 65 (1): 127–146. doi:10.1084/jem.65.1.127. PMC 2133474Freely accessible. PMID 19870585. 
  20. ^ Klenner FR (July 1949). "The treatment of poliomyelitis and other virus diseases with vitamin C". South Med Surg. 111 (7): 209–14. PMID 18147027. 
  21. ^ KAUFMAN W (July 1953). "Niacinamide therapy for joint mobility; therapeutic reversal of a common clinical manifestation of the normal aging process". Conn State Med J. 17 (7): 584–9. PMID 13060032. 
  22. ^ ALTSCHUL R, HOFFER A (April 1960). "The Effect of Nicotinic Acid on Hypercholesterolæmia". Can Med Assoc J. 82 (15): 783–5. PMC 1938010Freely accessible. PMID 13792994. 
  23. ^ Williams, Roger Lawrence (1998). Biochemical Individuality. New York: McGraw-Hill. ISBN 0-87983-893-0. 
  24. ^ Stone, Irwin (1982). The healing factor: "vitamin C" against disease. New York: Perigee Books. ISBN 0-399-50764-7. 
  25. ^ Sanford M, Curran MP (2008). "Niacin extended-release/simvastatin". Drugs. 68 (16): 2373–86. doi:10.2165/0003495-200868160-00008. PMID 18973399. 
  26. ^ Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (July 2000). "Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology". J. Clin. Oncol. 18 (13): 2505–14. PMID 10893280. 
  27. ^ Choi, Hyon K.; Xiang Gao; Gary Curhan (March 9, 2009). "Vitamin C Intake and the Risk of Gout in Men – A Prospective Study". Archives of Internal Medicine. 169 (5): 502–507. doi:10.1001/archinternmed.2008.606. PMC 2767211Freely accessible. PMID 19273781. 
  28. ^ Lin J, Cook NR, Albert C, et al. (January 2009). "Vitamins C and E and Beta Carotene Supplementation and Cancer Risk: A Randomized Controlled Trial". J. Natl. Cancer Inst. 101 (1): 14–23. doi:10.1093/jnci/djn438. PMC 2615459Freely accessible. PMID 19116389. 
  29. ^ Douglas RM, Hemilä H, Chalker E, Treacy B (2007). Hemilä H, ed. "Vitamin C for preventing and treating the common cold". Cochrane Database Syst Rev (3): CD000980. doi:10.1002/14651858.CD000980.pub3. PMID 17636648. 
  30. ^ Cabanillas, F (2010). "Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?". Puerto Rico health sciences journal. 29 (3): 215–7. PMID 20799507. 
  31. ^ a b Snodgrass SR (1992). "Vitamin neurotoxicity". Mol. Neurobiol. 6 (1): 41–73. doi:10.1007/BF02935566. PMID 1463588. 

External links[edit]